Statin and clinical outcomes of primary prevention in individuals aged >75 years: The SCOPE-75 study
Authors:
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 284, 31-36
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Science ICT and Future Planning (2015M3A9B6029138)
This publication has 33 references indexed in Scilit:
- Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional studyBMJ, 2012
- The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UKEuropean Heart Journal, 2011
- Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik StudyBMJ Open, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year oldsAge and Ageing, 2010
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Statins for Secondary Prevention in Elderly PatientsJACC, 2008
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002